BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33685573)

  • 1. Ezrin Promotes the Proliferation, Migration, and Invasion of Ovarian Cancer Cells.
    Li MJ; Xiong D; Huang H; Wen ZY
    Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
    Chen Z; Fadiel A; Feng Y; Ohtani K; Rutherford T; Naftolin F
    Cancer; 2001 Dec; 92(12):3068-75. PubMed ID: 11753986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
    Yan H; Sun BM; Zhang YY; Li YJ; Huang CX; Feng FZ; Li C
    Int J Mol Med; 2018 Nov; 42(5):2469-2480. PubMed ID: 30226564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
    Li J; Liang SH; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells.
    Singh SK; Mishra MK; Singh R
    J Ovarian Res; 2019 May; 12(1):42. PubMed ID: 31077234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 9. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells.
    Chen MJ; Gao XJ; Xu LN; Liu TF; Liu XH; Liu LX
    Int J Oncol; 2014 Oct; 45(4):1515-22. PubMed ID: 25051016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p.
    Mei J; Huang Y; Hao L; Liu Y; Yan T; Qiu T; Xu R; Xu B; Xiao Z; Jiang X; Hu K; Zhu Y
    Pathol Res Pract; 2019 Jul; 215(7):152452. PubMed ID: 31104928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.
    Fadiel A; Chen Z; Ulukus E; Ohtani K; Hatami M; Naftolin F
    Reprod Sci; 2012 Aug; 19(8):797-805. PubMed ID: 22477337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.
    Xi M; Tang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420930899. PubMed ID: 32674647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.
    He J; Ma G; Qian J; Zhu Y; Liang M; Yao N; Ding Q; Chen L; Liu X; Xia T; Wang S
    Med Sci Monit; 2017 Apr; 23():1583-1596. PubMed ID: 28364518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels.
    Salvi A; Thanabalu T
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1353-1359. PubMed ID: 27939884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
    Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
    PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
    Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
    Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
    Yang N; Wang L; Chen X; Liu J; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.